Learn More
BACKGROUND Unfractionated heparin and its low molecular weight fragments possess antithrombotic properties, properties that are routinely exploited in coronary angioplasty (PTCA). OBJECTIVES In the(More)
OBJECTIVES The study objectives were to describe (a) adaptation trajectories of elderly persons treated on a transitional unit for deconditioning and tracked after their return to the community, (b)(More)
O&&es. The specific objective of the REDUCE trial was to in the incidence of mqjor adverse events [i.e., death, myoeordial evaluate the e&t of low molecular weight beparin on the iociinlnrction, need(More)
OBJECTIVES The specific objective of the REDUCE trial was to evaluate the effect of low molecular weight heparin on the incidence and occurrence of restenosis in patients undergoing percutaneous(More)